Sabin Vaccine Institute Receives Additional $34.5M from BARDA for Further Development of Ebola Sudan and Marburg Vaccines Contracts + Grants October 21, 2021 …
Tonix Pharmaceuticals Opens Infectious Disease R&D Center in Maryland Industry News October 18, 2021 …
New Antiviral Compound Blocks SARS-CoV-2 From Entering Cells Medical Countermeasures October 13, 2021 …
Understanding How the Microbiome Affects Radiation Injury for Countermeasure Development CBRNE October 11, 2021 …
Breakthrough Results for Dengue Antiviral: Janssen Compound Shows Promise Against All Serotypes Industry News October 6, 2021 …
Dynavax and DoD Announce Collaboration to Develop an Adjuvanted Plague Vaccine Medical Countermeasures October 4, 2021 …
Made-in-Melbourne mAbs Could Bolster Australia’s COVID Response Medical Countermeasures September 29, 2021 …
Soligenix COVID-19 Vaccine Demonstrates Efficacy in Non-Human Primates Industry News September 28, 2021 …
Messenger RNA: How it Works in Nature and in Making Vaccines Medical Countermeasures September 6, 2021 …
RFI Supports Research on Impact of Nuclear Incident on the Microbiome and Development of Targeted Therapeutics CBRNE June 6, 2021 …
University of Bristol Scientists Form Halo Therapeutics to Develop ‘Pan-Corona’ Antivirals Industry News April 15, 2021 …
Thin Film Freezing Shows Efficacy for Biodefense Countermeasures Against Alphaviruses and Filoviruses Industry News February 19, 2021 …
New Vaccine Development Platform Could Fight Deadly, Multi-Drug Resistant Bacteria Antimicrobial Resistance January 30, 2021 …
Why Combining the Oxford COVID-19 Vaccine with Russia’s Sputnik V Could Make It More Effective Medical Countermeasures January 28, 2021 …
Defense Threat Reduction Agency Awards $75M for Antibiotic Drug Development Antimicrobial Resistance January 26, 2021 …
Novel Inhaled Vaccine for Tuberculosis Shows Strong Immune Response in Mice Medical Countermeasures January 18, 2021 …
